Metabolic and inflammatory markers: associations with individual depressive symptoms (Q47645248)

4 February 2018

title

Metabolic and inflammatory markers: associations with individual depressive symptoms (English)

1 reference

4 February 2018

F Lamers

1

0 references

Brenda Penninx

5

object named as

B W J H Penninx

1 reference

4 February 2018

author name string

Y Milaneschi

2

1 reference

4 February 2018

P de Jonge

3

1 reference

4 February 2018

E J Giltay

4

1 reference

4 February 2018

language of work or name

English

0 references

publication date

11 September 2017

1 reference

4 February 2018

published in

Psychological Medicine

1 reference

4 February 2018

page(s)

1-11

1 reference

4 February 2018

Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Augmentation of fluoxetine with lovastatin for treating major depressive disorder, a randomized double-blind placebo controlled-clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

High serum leptin levels in depressive disorders with atypical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Polygenic dissection of major depression clinical heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

A critical review of the efficacy of non-steroidal anti-inflammatory drugs in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

A meta-analysis of cytokines in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Habitual sleep duration is associated with BMI and macronutrient intake and may be modified by CLOCK genetic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

International physical activity questionnaire: 12-country reliability and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Should Depressive Syndromes Be Reclassified as "Metabolic Syndrome Type II"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Atypical depressive syndromes in varying definitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Obesity comorbidity in unipolar major depressive disorder: refining the core phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Prospective associations of depression subtypes with cardio-metabolic risk factors in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Depression with atypical features and increase in obesity, body mass index, waist circumference, and fat mass: a prospective, population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Identifying depressive subtypes in a large cohort study: results from the Netherlands Study of Depression and Anxiety (NESDA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Role of cytokines in atypical depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

The many different faces of major depression: it is time for personalized medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Late-life depression symptom profiles are differentially associated with immunometabolic functioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Metabolic depression: a chronic depressive subtype? Findings from the InCHIANTI study of older persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

The subtypes of major depression in a twin registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Inflammation and Specific Symptoms of Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

The prevalence and predictors of obstructive sleep apnea in major depressive disorder, bipolar disorder and schizophrenia: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Gene expression in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Research domain criteria (RDoC): toward a new classification framework for research on mental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Prevalence of metabolic syndrome in subjects with melancholic and non-melancholic depressive symptoms. A Finnish population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Relationship between obesity and the risk of clinically significant depression: Mendelian randomisation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Drug targeting of leptin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

C-reactive protein is elevated in atypical but not nonatypical depression: data from the National Health and Nutrition Examination survey (NHANES) 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Elevated IL-6 levels in patients with atypical depression but not in patients with typical depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

The associations between psychopathology and being overweight: a 20-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Cytokines sing the blues: inflammation and the pathogenesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Associations between depression subtypes, depression severity and diet quality: cross-sectional findings from the BiDirect Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Associations between mood, anxiety or substance use disorders and inflammatory markers after adjustment for multiple covariates in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

The epidemiology of adult obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

Leptin Dysregulation Is Specifically Associated With Major Depression With Atypical Features: Evidence for a Mechanism Connecting Obesity and Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

The effect of FTO rs9939609 on major depression differs across MDD subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

7 January 2021

Mood, food, and obesity

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

7 January 2021

Clinical subtypes of depression are associated with specific metabolic parameters and circadian endocrine profiles in women: the power study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

7 January 2021

Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

7 January 2021

Serum proteomic profiles of depressive subtypes

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

7 January 2021

Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

7 January 2021

Obesity genes and risk of major depressive disorder in a multiethnic population: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291717002483

7 January 2021

10.1017/S0033291717002483

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018